These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 21871956)

  • 1. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.
    Mao P; Reddy PH
    Biochim Biophys Acta; 2011 Nov; 1812(11):1359-70. PubMed ID: 21871956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.
    Reddy PH; Beal MF
    Trends Mol Med; 2008 Feb; 14(2):45-53. PubMed ID: 18218341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
    Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective mitophagy in Alzheimer's disease.
    Pradeepkiran JA; Reddy PH
    Ageing Res Rev; 2020 Dec; 64():101191. PubMed ID: 33022416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
    Reddy PH
    Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
    Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
    Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects.
    Müller WE; Eckert A; Kurz C; Eckert GP; Leuner K
    Mol Neurobiol; 2010 Jun; 41(2-3):159-71. PubMed ID: 20461558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.
    Leuner K; Müller WE; Reichert AS
    Mol Neurobiol; 2012 Aug; 46(1):186-93. PubMed ID: 22833458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
    Manabe T; Matsumura A; Yokokawa K; Saito T; Fujikura M; Iwahara N; Matsushita T; Suzuki S; Hisahara S; Kawamata J; Suzuki H; Emoto MC; Fujii HG; Shimohama S
    J Alzheimers Dis; 2019; 67(3):1079-1087. PubMed ID: 30714961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial secret(ase) of Alzheimer's disease.
    Young KJ; Bennett JP
    J Alzheimers Dis; 2010; 20 Suppl 2():S381-400. PubMed ID: 20442493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
    Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
    Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.